Nektar Therapeutics regains Nasdaq minimum bid price compliance

NEKTAR THERAPEUTICS

Received Nasdaq deficiency notice on April 3, 2025 for bid price below $1.00.
Regained compliance on June 23, 2025 after 10 consecutive trading days above $1.00.
Nasdaq confirmed compliance in a letter dated June 24, 2025.
Company continues to trade on The Nasdaq Capital Market under symbol NKTR.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.